Raw materials are foundational elements in manufacturing safe, high-quality, and efficacious biological products (1–3). The inherent complexity and sensitivity of biologics necessitate robust risk-management strategies across their development and manufacture (4). Raw-material risk assessments provide a structured framework to identify and control risks — such as variability, contamination, and instability (Figure 1) — that can influence the final product (1, 5).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Tyler
Contact Tyler, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack